Skip to content
EmergingResearch compoundReference only

Aloracetam

Experimental nootropic developed against Alzheimer's disease; virtually untested in humans and never marketed.

NootropicRacetamRacetamAcetylcholineAcetylcholineAMPA

Pharmacology

ClassRacetam · Acetylcholine
Primary targetProposed acetylcholine enhancement (unconfirmed)
Targets2 receptor targets
Half-lifeN/A
OnsetN/A
EvidenceReference only
Affected systemsAcetylcholineAMPA

Contents

DETAILED OVERVIEW

What is Aloracetam?

Aloracetam is an experimental compound that a drug company studied for treating Alzheimer's disease, but development was stopped and it never reached the market. It is not an approved medicine and not a dietary supplement either. Despite its name, it is not a classic racetam in structure.

How it works is barely known in the public literature; it was suggested that it raises levels of acetylcholine, a messenger chemical in the brain, but this is unconfirmed. Only early research data exist and it has virtually never been tested in humans, so there is no reliable data on its effects, side effects, long-term safety or interactions with other drugs. There is no safety data for pregnancy or breastfeeding. For now it is more a curiosity of research history than a proven product.

Mechanism

Uncharacterized (proposed cholinergic)

Half-life

N/A

Onset

N/A

Legal status

Unapproved medicine; unscheduled in the US

Receptor profile

  • Acetylcholine systemWeak
  • AMPA receptorsWeak

Safety

Side effects, stop signs, contraindications

Side effects · 3

  • With virtually no human data, the side-effect profile is unknown; racetam-like effects such as headache are plausible but unconfirmed
  • Theoretical choline-depletion headache, as with other racetams; a choline source may help in principle
  • Unknown long-term safety: never marketed and development was discontinued

Contraindications · 3

  • Pregnancy and breastfeeding: no safety data, should be avoided
  • Not a medicine: human clinical trials have not established its safety, any use is experimental
  • Unknown drug interactions: the mechanism is uncharacterized, so co-administration risk cannot be estimated

Related Nootropics

Same therapeutic category

FAQ

FAQ

Aloracetam is an obscure experimental compound that a pharmaceutical company once studied as a potential Alzheimer's treatment, but development was discontinued and it was never brought to market. In theory it might support memory and cognition through a brain-chemistry pathway, but this was essentially never tested in humans, so today it's mostly a research and historical curiosity rather than a proven, ready-to-use substance.

Telegram

Have a question about Aloracetam?

Reach out to us on Telegram for a personalized stack. We'll be happy to help.

Personalized consultation

Want a detailed conversation tailored to your data?

Fill out the prep intake form (your goals, training and health data), and the advisor prepares from it to give genuinely personalized guidance.

Fill out the form

~5–7 min · prep questionnaire · confidential · GDPR-compliant

Structure & chemistry

TypeNootropic
FormulaC11H16N2O2
UpdatedOctober 13, 2026
MolekulaX Editorial Team·Source-verified · PubMed · FDA · EMA
Updated: October 13, 2026

The information here is strictly for educational and scientific purposes. It does not replace medical advice or clinical consultation, and it does not encourage illegal substance or pharmaceutical use. Data is sourced. When in doubt, consult your doctor.